CORRECTING and REPLACING Snyder Joins Micro Bio-Medical Waste Systems, Inc. Administrative Team as EVP of Business Development.

Business Editors

CORRECTION...by Micro Bio-Medical Waste Systems, Inc.

LAS VEGAS--(BUSINESS WIRE)--May 17, 2004

In BW5086 issued May 16, 2004: Second graph, first sentence of release should read: A graduate of Princeton University with an MBA from Harvard Business School, Mr. Snyder brings over 30 years of successful business experience to MBWS.

The corrected release reads:

SNYDER JOINS MICRO BIO-MEDICAL WASTE SYSTEMS, INC. ADMINISTRATIVE TEAM AS EVP OF BUSINESS DEVELOPMENT

Micro Bio-Medical Waste Systems, Inc. (OTCBB:MBWS) announced today that Tom Snyder has agreed to assume the responsibilities of Executive Vice President of Business Development.

A graduate of Princeton University with an MBA from Harvard Business School, Mr. Snyder brings over 30 years of successful business experience to MBWS. Mr. Snyder began his career as Budget Officer for MACV-SOG in Saigon from 1969 to 1970. He continued his career as a Senior Financial Analyst with Baxter International before moving in 1974 to Georgia, where he acquired and managed a multiunit retail business until 1988. From 1988 until the present, Mr. Snyder has offered consulting services to the healthcare industry, served as a member of the faculty of the University of Georgia, specialized in securing seed capital for early stage, developmental companies and corporations. As a direct result of Mr. Snyder's efforts on behalf of these entities, $56,000,000 was raised for growth and operating capital.

New CEO and President Stephen D. Cummins commented on Snyder's hiring, "This is a banner day for Micro Bio-Medical Waste Systems and our shareholder base. We are indeed fortunate to welcome Tom to our administrative team. He is a brilliant business strategist, manager and visionary, and brings a solid synergistic background of experience to MBWS. These attributes coupled with his business ethic provide MBWS with a solid administrative foundation moving forward."

Micro Bio-Medical Waste Systems' mission is to build a solidly profitable company whose management is characterized by decisions reflecting integrity with a focus on building shareholder value. Micro Bio-Medical Waste Systems will execute this mission through continuing to build a strong administrative and technical team and profitably through the processing of medical waste feed stocks using its proprietary technology. Micro Bio-Medical Waste Systems' processing system will allow the company to achieve profitable yields from globally abundant medical waste producers.

Micro Bio-Medical Waste Systems, Inc. trades on the OTCBB with a ticker symbol MBWS.

This release may be deemed to contain forward-looking statements, which are subject to the safe harbor provisions of the Private Litigation Reform Act of 1995. These forward-looking statements include, among other things, statements regarding future events and the future financial performance of Micro Bio-Medical Waste Systems that involve risks and uncertainties. Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual future events or results. Readers are referred to the documents filed by Micro Bio-Medical Waste Systems with the SEC, specifically the most recent reports on Form 10-K and 10-Q, each as it may be amended from time to time, which identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. Among the important factors or risks that could cause actual results or events to differ materially from those in the forward-looking statements in this release are: business and economic conditions and growth trends in our industry in various geographic regions; global economic conditions and uncertainties in the geopolitical environment; variations in customer demand for products and services; variability of operational costs; variations in sales channels, product costs, or mix of products sold; the ability to successfully acquire businesses and technologies and to successfully integrate and operate these acquired businesses and technologies; dependence on the introduction and market acceptance of our technology and expansion into other industry segments; rapid technological and market change; litigation involving patents, intellectual property, stockholder and other matters; the ability to recruit and retain key personnel; financial risk management; our ability to raise capital to fund our operations and expansion plans; and potential volatility in operating results, among others.